Valink Therapuetics

Discovering bispecific antibody drug-conjugates (BsADC) against cancer

Based based in Boston, MA, USA, Valink Therapuetics works in vc portfolio.

Profile

Valink Therapeutics develops next generation antibody-based therapeutics. We identify novel mechanism of action from known targets by incorporating multiple antibody modifications at once, rapidly and scalable generating complex drug candidates (bi-/multispecificity, multivalency and drug-conjugation in a single discovery process). Our research focus is on solid tumours poorly addressed by immunotherapy.

Its activity falls under vc portfolio; the profile below is assembled from public directory data.

Its base of operations is Boston, MA, USA.

Its current recorded stage is Winter 2021.

The company reports a headcount in the 15 range.

Website: www.valinktx.com